RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..3 of 3 - per page
Order by
Acquisition of UK Primary Care ethical brands
Strategic divestments of primary care sales focussed brands More
Injectables and oral medicines for hospital use
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets More
Novel, ready-to-market, next generation of pain relief patch product sought for topical analgesic leader
Our analgesic specialists are seeking a new, innovative and novel patch product for the treatment of pain to add to their portfolio. More
Displaying 1..3 of 3 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Company Financials: Alexza Pharmaceuticals
Jan 2010 - $75
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010
Aug 2010 - 76 pages - $1,500
Emerging Technologies: Stem cells
Nov 2011 - 61 pages - $3,800
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - June 2010
Jun 2010 - 67 pages - $1,000
Pharmaceutical & Healthcare Annual Deals Analysis 2011
Mar 2011 - 107 pages - $3,500
Company Financials: Cephalon, Inc
Jan 2010 - $75
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us